Navigation Links
Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View

ST. LOUIS, Dec. 16, 2011 /PRNewswire/ -- Veran Medical Technologies announced today the release of its SPiN Drive™ platform upgrade for bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously. This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked™ instrument in a fluoro-like view without any radiation being delivered to the patient, physician or staff.


"The significance of targeting Solitary Pulmonary Nodules (SPNs) without radiation is exciting," said Alexander C. Chen, M.D., of Washington University, St. Louis, MO. "The virtual fluoroscopic view provides images that the majority of bronchoscopists utilize while targeting solitary pulmonary nodules, without the radiation exposure. Additionally, the ability to map airways during procedures may provide a significant advantage towards targeting SPNs."

"This enhancement is ground-breaking technology," said Mark Hunter, vice president of strategic operations at Veran Medical Technologies. "Auto-rotate fly-through view makes instrument steering more intuitive and consistent with the user's standard bronchoscopic view."

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. Diagnosing lung cancer at Stage I improves survival chances significantly. Due to the 69 million CT scans that occur annually in the United States, inadvertent lung cancer screening is occurring. However, SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. healthcare system. Veran's SPiN Drive™ product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs and immediately diagnose malignancy, end watchful waiting and reduce healthcare spending.

About Veran Medical Technologies, Inc.

Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body. The company believes that by enabling minimally invasive early stage treatments, it can increase patient survival and lower healthcare costs significantly. Veran Medical Technologies is headquartered in St. Louis, MO.

SOURCE Veran Medical Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
2. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
3. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
4. MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation
5. Dehaier Medical Enters European Homecare Medical Product Market
6. Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
7. Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012
8. Medical Device Costa Rica: An MPO Symposium Helps Firms Connect, Learn & Master Global Manufacturing Skills
9. TransTech Medical Solutions Ranked #1 by KLAS for 2011
10. FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices
11. MedShape, Inc. Awarded U.S. Patent for Deploying Shape Memory Polymer Devices in Medical Applications
Post Your Comments:
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... ) has announced the addition of ... Testing Market: Campylobacter, Cryptosporidium, E. Coli, ... Yersinia" report to their offering. ... announced the addition of the ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... --  Craneware, Inc ., the healthcare market leader ... company will showcase a new version of its ... at the American Society for Health-System Pharmacists (ASHP) ... features are focused on simplifying and streamlining the ... pharmacy charges to ensure compliance and optimal revenue ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- ... of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - CES, Las Vegas, ... Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, where they will ... Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among ...
Breaking Medicine News(10 mins):